Journal of NeuroVirology
|
|
February 2000, Volume 6, Issue 1, Pages 51 - 60 |
![]() |
Journal Home |
||
<- Previous | Issue Contents | Next -> |
Article |
Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides
Correspondence to: |
Keywords |
HIV-1 associated dementia;
gp41;
CD59;
protein kinase inhibitor;
proinflammatory cytokines;
antioxidants;
anti-inflammatory agents |
Abstract |
In attempts to elucidate the pathogenic mechanisms involved in neurodegeneration in AIDS patients with cognitive deficits, the possible effect of HIV-1 transmembrane envelope protein gp41 on expression of the membrane inhibitor of complement mediated cytolysis (CD59) was assessed in human neuronal (SK-N-SH) and astroglial (T98G) cell lines. Western blotting analyses demonstrated that an immunodominant (ID, aa 598 - 613) gp41 peptide as well as the recombinant gp41 protein encompassing this domain markedly reduced CD59 level in a dose dependent manner whereas p24 and control peptide had little effect. RT - PCR showed that ID peptide also elicited a reduction in the expressed CD59 mRNA level. This gp41 peptide apparently down-regulated phorbol 12,13-dibutyrate induced elevation of CD59 at the protein and mRNA levels in a manner similar to that conferred by protein kinase C inhibitor, H-7 or staurosporine in SK-N-SH. Interestingly, proinflammatory cytokines such as IL-1 |
Received 6 April 1999; Revised 27 August 1999; Accepted 9 September 1999